Showing results (11-20 of 283) with videos related to
Sort By:
Pageof 29
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2002
[Rituximab, a chimeric anti-CD20 monoclonal antibody, in the treatment of B-cell lymphoma]Kensei TobinaiInternational Journal of Clinical Oncology|October 12, 2007
Proteasome inhibitor, bortezomib, for myeloma and lymphomaKensei TobinaiInternational Journal of Hematology|January 7, 2003
Monoclonal antibody therapy for B-cell lymphoma: clinical trials of an anti-CD20 monoclonal antibody for B-cell lymphoma in JapanKensei TobinaiExpert Opinion on Emerging Drugs|July 2, 2005
Rituximab and other emerging monoclonal antibody therapies for lymphomaKensei TobinaiNihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2014
[The progress in treatment for malignant lymphomas and the future direction]Wataru Munakata, Kensei TobinaiJapanese Journal of Clinical Oncology|September 3, 2004
Clinical trials for malignant lymphoma in JapanKensei Tobinai, Tomomitsu HottaLeukemia Research and Treatment|December 22, 2012
Clinical Trials and Treatment of ATLKunihiro Tsukasaki, Kensei TobinaiExpert Opinion on Drug Discovery|September 7, 2016
The discovery and the development of bendamustine for the treatment of non-Hodgkin lymphomaWataru Munakata, Kensei TobinaiExpert Opinion on Biological Therapy|June 27, 2017
Mogamulizumab for the treatment of T-cell lymphomaShinichi Makita, Kensei TobinaiHematology. American Society of Hematology. Education Program|February 20, 2015
Screening for and management of hepatitis B virus reactivation in patients treated with anti-B-cell therapyShigeru Kusumoto, Kensei TobinaiPageof 29